FDA advisory panel okays Sprout’s drug to cure sexual desire disorder in women
The FDA’s joint meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee, and the Drug Safety and Risk Management Advisory Committee have voted 18 to 6 vote